loading

Kura Oncology Inc Aktie (KURA) Neueste Nachrichten

pulisher
Jul 24, 2025

Is Kura Oncology Inc. a good long term investmentFree Real-Time Stock Data - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Will Kura Oncology Inc. stock benefit from interest rate changesFree Stock Chart Pattern Guide - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Can Kura Oncology Inc. stock recover from recent declineFree Predictions - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about Kura Oncology Inc. stockExplosive returns - Autocar Professional

Jul 24, 2025
pulisher
Jul 22, 2025

What drives Kura Oncology Inc. stock priceAccelerated wealth building - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Kura Oncology Inc. Stock Analysis and ForecastExplosive earnings growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 18, 2025

Kura Oncology, Inc. (NASDAQ:KURA) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Jul 18, 2025
pulisher
Jul 16, 2025

Why Kura Oncology Inc. stock attracts strong analyst attentionFree AI-Driven Trading Strategies - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Menin Inhibitors Market Forecasts Signal Strong Uptake of Menin Inhibitors in Hematologic Oncology Across the 7MM During the Forecast Period (2020-2034) | DelveInsight - Yahoo Finance

Jul 15, 2025
pulisher
Jul 15, 2025

How Kura Oncology Inc. stock performs during market volatilityFree Access to Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Kura Oncology Inc. stock price move sharplyHigh Reward Risk Balanced Trading - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Health Check: How Prudently Does Kura Oncology (NASDAQ:KURA) Use Debt? - simplywall.st

Jul 14, 2025
pulisher
Jul 10, 2025

Wealth Enhancement Advisory Services LLC Takes $139,000 Position in Kura Oncology, Inc. (NASDAQ:KURA) - Defense World

Jul 10, 2025
pulisher
Jul 03, 2025

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jul 03, 2025
pulisher
Jul 03, 2025

Kura Oncology shares rise 3.34% after-hours following inducement grants to new employees. - AInvest

Jul 03, 2025
pulisher
Jul 02, 2025

Kura Oncology's Ziftomenib: A Near-Term FDA Catalyst and a Paradigm Shift for AML Patients - AInvest

Jul 02, 2025
pulisher
Jul 01, 2025

Kura Oncology Partners with Kyowa Kirin for Ziftomenib - TipRanks

Jul 01, 2025
pulisher
Jul 01, 2025

Kura Oncology and Kyowa Kirin enter agreement to co-promote leukemia drug in US - Investing.com

Jul 01, 2025
pulisher
Jul 01, 2025

Kura Oncology and Kyowa Kirin enter agreement to co-promote leukemia drug in US By Investing.com - Investing.com South Africa

Jul 01, 2025
pulisher
Jun 29, 2025

Kura Oncology, Inc.(NasdaqGS: KURA) added to Russell 3000E Value Index - MarketScreener

Jun 29, 2025
pulisher
Jun 27, 2025

Kura Oncology (NASDAQ:KURA) Given Overweight Rating at Cantor Fitzgerald - Defense World

Jun 27, 2025
pulisher
Jun 26, 2025

KURA: Cantor Fitzgerald Reiterates Overweight Rating | KURA Stoc - GuruFocus

Jun 26, 2025
pulisher
Jun 22, 2025

Kura Oncology, Inc. (NASDAQ:KURA) Shares Acquired by Rhumbline Advisers - Defense World

Jun 22, 2025
pulisher
Jun 20, 2025

KURA: Wedbush Reiterates 'Outperform' Rating with $36 Price Target | KURA Stock News - GuruFocus

Jun 20, 2025
pulisher
Jun 18, 2025

Transcript : Kura Oncology, Inc.Special Call - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Kura Oncology Announces Positive Phase 1a/1b Trial Results - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

Long Term Trading Analysis for (KURA) - news.stocktradersdaily.com

Jun 18, 2025
pulisher
Jun 17, 2025

Kura Oncology rises after new early-stage trial data for leukemia therapy - MSN

Jun 17, 2025
pulisher
Jun 15, 2025

Pallas Capital Advisors LLC Invests $66,000 in Kura Oncology, Inc. (NASDAQ:KURA) - Defense World

Jun 15, 2025
pulisher
Jun 15, 2025

Kura Oncology, Inc. (NASDAQ:KURA) Shares Sold by Harbor Capital Advisors Inc. - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

Kura Oncology’s SWOT analysis: ziftomenib’s potential reshapes AML treatment stock outlook - Investing.com Australia

Jun 14, 2025
pulisher
Jun 13, 2025

Kura Oncology’s SWOT analysis: ziftomenib’s potential reshapes AML treatment stock outlook By Investing.com - Investing.com South Africa

Jun 13, 2025
pulisher
Jun 12, 2025

KURA's Ziftomenib Shows Promising Results in AML Clinical Trial - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology reports positive data for AML treatment ziftomenib By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 12, 2025

Is the Options Market Predicting a Spike in Kura Oncology Stock? - The Globe and Mail

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology (KURA) Shows Promising Results for AML Therapy - GuruFocus

Jun 12, 2025
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Kapitalisierung:     |  Volumen (24h):